Login to Your Account



Financings Roundup

Moderna Makes Entrance with $40M Round for mRNA Work

By Catherine Shaffer
Staff Writer

Thursday, December 6, 2012

Moderna Therapeutics emerged from stealth mode with a $40 million financing led by Flagship Ventures and a consortium of private investors. Moderna is developing a platform technology for delivery of messenger RNA (mRNA) to stimulate production of therapeutic proteins in the cells.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription